Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.

Brain tumor pathology - 1 Apr 2018

Iuchi Toshihiko, Sugiyama Takahiro, Ohira Miki, Kageyama Hajime, Yokoi Sana, Sakaida Tsukasa, Hasegawa Yuzo, Setoguchi Taiki, Itami Makiko

Abstract excerpt

In this study, we retrospectively compared the prognostic value of the 2016 WHO classification with the former classification in 387 patients with glioma treated at our institution. According to the new classification, diagnoses included oligodendroglioma with isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion (5.4%), anaplastic oligodendroglioma with IDH mutation and 1p/19q co-deletion (3.4%),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to MAP Kinase Signaling System

Share to Oligodendroglioma

Share to World Health Organization

Source

Identifiers

PMID: 29470683
DOI: 10.1007/s10014-018-0309-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.PMID 29470683Read ↗

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.Semantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification.Semantic proximity Read ↗

Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients.Semantic proximity Read ↗

[Advance of molecular subtyping and precise treatment for gliomas].Semantic proximity Read ↗

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.Semantic proximity Read ↗

The 2007 WHO classification of tumors of the central nervous system – what has changed?Semantic proximity Read ↗

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].Semantic proximity Read ↗

New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.Semantic proximity Read ↗

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.